COVID-19 RESOURCE CENTER

Our experts are publishing articles and supporting companies that are working with health solutions to help solve the global pandemic.

Published in major journals and media, the following features are tracking the evolving developments of the COVID-19 pandemic.

Five Actions Essential to Supercharge BC’s Life Sciences Industry

British Columbia and the Vancouver region in particular has a proud history of supporting globally impactful life sciences organizations, and the industry employs an estimated one in 140 workers in the province.

Featured in

Vancouver Economic Commission

Date

Jun 23, 2021

Supercharge, British Columbia, Life Sciences, Business, Investment, Venture Capital, Biotech, COVID-19

Five Actions Essential to Supercharge BC’s Life Sciences Industry

Canadian COVID-19 Vaccine Shows Promise in Clinical Trials

Featured in

The Globe and Mail Canada

Date

May 17, 2021

COVID-19, coronavirus, SARS-CoV-2, Vaccine, Canada

Canadian COVID-19 Vaccine Shows Promise in Clinical Trials

How COVID-19 Vaccines Developed in China, Russia and Elsewhere Could Impact the Pandemic

Featured in

CBC

Date

May 10, 2021

COVID-19, coronavirus, SARS-CoV-2, Vaccine

How COVID-19 Vaccines Developed in China, Russia and Elsewhere Could Impact the Pandemic

Not Available in Canada: A Look at COVID-19 Vaccine Tech from China, India and Cuba

COVID-19 vaccines developed in China are already being used in several countries around the world. And some developed in India, Kazakhstan and Cuba have been in use domestically for their own populations even before completion of Phase 3 trials.

Featured in

CBC

Date

May 04, 2021

COVID-19, coronavirus, SARS-CoV-2, Vaccine

Not Available in Canada: A Look at COVID-19 Vaccine Tech from China, India and Cuba

Does the AstraZeneca Vaccine Cause More Common Side-Effects Than Others? Your Coronavirus Questions Answered

Featured in

CBC

Date

Apr 28, 2021

COVID-19, coronavirus, SARS-CoV-2, Vaccine

Does the AstraZeneca Vaccine Cause More Common Side-Effects Than Others? Your Coronavirus Questions Answered

A New Study by Novateur Ventures Provides Global Analysis of COVID-19 Vaccines

A new study by Novateur Ventures provides a comparative analysis of twelve COVID-19 Vaccines that had initiated or announced the Phase III clinical trial stage by early November 2020.

Featured in

MDPI Viruses - EurekAlert!

Date

Mar 18, 2021

COVID-19, coronavirus, SARS-CoV-2, Vaccine

A New Study by Novateur Ventures Provides Global Analysis of COVID-19 Vaccines

New Study Identifies Top-Performing Point-of-Care COVID-19 Tests

Researchers at NSF International and Novateur Ventures screen rapid-detection COVID-19 tests for clinical sensitivity/specificity, limit of detection and time to results

Featured in

MDPI Diagnostics - EurekAlert!

Date

Feb 10, 2021

COVID-19, coronavirus, SARS-CoV-2, point-of-care tests, diagnostics, POC Diagnostics

New Study Identifies Top-Performing Point-of-Care COVID-19 Tests

CA Healthcare Providers Call To Reopen Schools

Featured in

Fox News Media

Date

Feb 09, 2021

COVID-19, Pandemic, Lockdown, SARS-SoV-2, coronavirus, testing, serology testing, diagnostics, transmission

CA Healthcare Providers Call To Reopen Schools

COVID-19 Vancouver-Headquartered Venture Firm Seeks to Enter Testing Fray

Firm makes case that its antibody test would be useful layer of information to help keep economy open.

Featured in

Vancouver Sun

Date

Oct 29, 2020

COVID-19, SARS-CoV-2, coronavirus, antibody tests, serological tests, diagnostics, Canada, Health Canada

COVID-19 Vancouver-Headquartered Venture Firm Seeks to Enter Testing Fray

Novateur Ventures: Overlooked Generic Drug Strategy May Prevent COVID-19’s Cytokine Storm

Two generic anti-inflammatory drugs typically used in asthma treatments are being proposed for use with COVID-19 because of their potential to dampen disease progression and severity.

Featured in

BioSpace

Date

Aug 19, 2020

COVID-19, SARS-CoV-2, leukotrienes, cytokine storm, coronavirus, inflammatory response, vascular leak, clinical trial

Novateur Ventures: Overlooked Generic Drug Strategy May Prevent COVID-19’s Cytokine Storm

Novateur Study Points Toward Potential COVID-19 Treatment

Researchers at Novateur Ventures have released a strategy that examines leukotrienes as the cause for hyperinflammatory response in severe cases

Featured in

Outsourcing Pharma

Date

Aug 17, 2020

COVID-19, SARS-CoV-2, leukotrienes, cytokine storm, coronavirus, inflammatory response, vascular leak, clinical trial, preclinical, reasearch

Novateur Study Points Toward Potential COVID-19 Treatment

Novateur Ventures Explores New Strategy to Reduce the Hyperinflammatory Response Caused by COVID-19

A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled ‘A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes’ was published in Frontiers in Pharmacology, a leading peer-reviewed journal. The strategy co-authored by Ali Ardakani, Founder & Managing Director at Novateur Ventures, and Dr. Colin D. Funk (Queen's University, Kingston) analyzes lipid mediators, known as leukotrienes, as the cause for hyperinflammatory response manifested in severe COVID-19 cases. Patients with severe COVID-19 develop an overwhelming state of inflammation with multi-organ dysfunction and leukotrienes have been overlooked.

Featured in

GlobeNewswire

Date

Aug 06, 2020

COVID-19, SARS-CoV-2, leukotrienes, cytokine storm, coronavirus, inflammatory response, vascular leak, clinical trial

Novateur Ventures Explores New Strategy to Reduce the Hyperinflammatory Response Caused by COVID-19

Importance of Serology Testing in Fight Against COVID-19

Featured in

Global News TV

Date

Jul 26, 2020

COVID-19, SARS-SoV-2, coronavirus, testing, serology testing, diagnostics

Importance of Serology Testing in Fight Against COVID-19

COVID-19 Antibody Testing Has Yielded Useful Data for Public Health but Cautions for Individual Use

Researchers have learned valuable lessons from COVID-19 antibody testing in the population, including those about the challenges in using the method at an individual level.

Featured in

The Province

Date

Jul 26, 2020

COVID-19, SARS-CoV-2, coronavirus, antibody tests, serological tests, diagnostics, Canada, Health Canada

COVID-19 Antibody Testing Has Yielded Useful Data for Public Health but Cautions for Individual Use

A New Study Evaluated the Accuracy of More Than 60 Coronavirus Antibody Tests. 13 Were a Cut Above the Rest.

Hopes were high when the first coronavirus antibody tests debuted a few months ago. There was talk of issuing immunity passports based on the results. The tests were so coveted in the US that the Food and Drug Administration allowed some to go straight to market.

Featured in

Business Insider

Date

Jul 23, 2020

COVID-19, SARS-CoV-2, coronavirus, antibody tests, serological tests, diagnostics, Emergency Use Authorization, EUA, FDA

A New Study Evaluated the Accuracy of More Than 60 Coronavirus Antibody Tests. 13 Were a Cut Above the Rest.

Antibody Survey Reveals ‘Widespread Vulnerability’ to COVID-19 Across Canada, Expert Says

Fewer than 1 per cent of Canadians have had the virus that causes COVID-19, according to initial findings from the largest serological survey conducted to date across the country. The results, released Thursday, are based on 10,000 anonymized blood donations. They offer the best glimpse so far at the extent of the disease beyond the official count of confirmed cases, which now stands at just more than 112,000. The actual number of cases could be three times that, although sample size and testing uncertainties mean it is not yet possible to make a more precise estimate.

Featured in

The Globe & Mail

Date

Jul 23, 2020

COVID-19, SARS-CoV-2, coronavirus, antibody tests, serological tests, diagnostics, Canada

Antibody Survey Reveals ‘Widespread Vulnerability’ to COVID-19 Across Canada, Expert Says

Quest Wins EUA for Four-Swab Pooling via PCR Diagnostic; Hahn Says ‘Important Step Forward’

The U.S. FDA announced July 18 that it has granted an emergency use authorization (EUA) to Quest Diagnostics Inc. for the company’s real-time, reverse transcriptase polymerase chain reaction test for the SARS-CoV-2 virus in a development that FDA commissioner Stephen Hahn described as “an important step forward.”

Featured in

BioWorld

Date

Jul 20, 2020

COVID-19, SARS-CoV-2, coronavirus, diagnostics, Emergency Use Authorization, EUA, FDA

Quest Wins EUA for Four-Swab Pooling via PCR Diagnostic; Hahn Says ‘Important Step Forward’

New Study Ranks Performance of Currently Available COVID-19 Antibody Tests

Conducted by researchers at NSF International and Novateur Ventures, the peer-reviewed study finds significant variability in the accuracy of available COVID-19 antibody tests

Featured in

American Association for the Advancement of Science (AAAS) - EurekAlert!

Date

Jul 15, 2020

COVID-19, coronavirus, SARS-CoV-2, antibody tests, diagnostics, FDA, EUA, Emergency Use Authorization

New Study Ranks Performance of Currently Available COVID-19 Antibody Tests

The Pandemic Spotlights Emerging Targets for M&A

Featured in

Middle Market Growth magazine

Date

Jul 14, 2020

COVID-19, SARS-CoV-2, coronavirus, global pandemic

The Pandemic Spotlights Emerging Targets for M&A

Ali Ardakani of Novateur Ventures: How We Plan to Rebuild in the Post COVID Economy

Adaptation is the key to success. Seek opportunities during the COVID-19 times to advance your healthcare innovation. This is something that nature does well, and that we should learn from: rapid development to new information and the integration of that wisdom to respond with collective intelligence in the future.

Featured in

Authority Magazine

Date

Jul 06, 2020

COVID-19, business, economy, moving forward, Post-Covid

Ali Ardakani of Novateur Ventures: How We Plan to Rebuild in the Post COVID Economy

We keep our
finger on the
pulse of the
health industry.

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Sign Up
Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Drugbank Expertscape
Relevant Events

Check out conferences and events we are attending!

Featured Events Recent Events Past Events